Luckwel Pharmaceuticals Inc. announced earnings results for the third quarter ended December 31, 2018. For the third quarter, the company announced net loss was USD 262,810 compared to USD 126,834 a year ago. Basic loss per share from continuing operations was USD 0.002 compared to USD 0.007 a year ago. For the nine months, net loss was USD 642,262 compared to USD 392,656 a year ago. Basic loss per share from continuing operations was USD 0.005 compared to USD 0.021 a year ago.